BioStem Technologies Inc (OTCMKTS:BSEM) Stock On Watchlist After Q3 Earnings

November 16, 2022

This morning there may be plenty of investors who are going to take a look into the BioStem Technologies Inc (OTCMKTS:BSEM) stock after the company announced its financial results for the third fiscal quarter that was ended on September 30, 2022. Trading Data On Tuesday, BSEM stock ended flat at $3.7500 with more than 15 shares traded, compared to volume of 2.78K shares. The stock moved within a range of…


BioStem Technologies Inc (OTCMKTS:BSEM) Stock In Focus After New Appointment

September 9, 2022

Leading regenerative medicine company focusing on developing, manufacturing, and commercialization of placental derived tissue allografts, BioStem Technologies Inc (OTCMKTS:BSEM), on September 8, 2022, announced the appointment of Brandon Poe as Independent Board Member as well as Chair of the Audit Committee. Trading Data On Thursday, BSEM stock decreased 0.66% to $2.2700 with more than 300 shares, compared to its average volume of 3.10K shares. The stock moved within a range…